Masked hypertension (MHT), defined as nonelevated blood pressure (BP) in the clinic setting and elevated BP assessed by ambulatory monitoring, is associated with increased risk of target organ damage, cardiovascular disease, and mortality. Currently, no estimate of MHT prevalence exists for the general US population. After pooling data from the Masked Hypertension Study (n = 811), a cross-sectional clinical investigation of systematic differences between clinic BP and ambulatory BP (ABP) in a community sample of employed adults in the New York City metropolitan area (2005–2012), and the National Health and Nutrition Examination Survey (NHANES;

https://ainolehti.tumblr.com/

2005–2010; n = 9,316), an ongoing nationally representative US survey, we used multiple imputation to impute ABP-defined hypertension status for NHANES participants and estimate MHT prevalence among the 139 million US adults with nonelevated clinic BP, no history of overt cardiovascular disease, and no use of antihypertensive medication. The estimated US prevalence of MHT in 2005–2010 was 12.3% of the adult population (95% confidence interval: 10.0, 14.5)—approximately 17.1 million persons aged ?21 years.

https://catamari.tumblr.com/

Consistent with prior research, estimated MHT prevalence was higher among older persons, males, and those with prehypertension or diabetes. To our knowledge, this study provides the first estimate of US MHT prevalence—nearly 1 in 8 adults with nonelevated clinic BP—and suggests that millions of US adults may be misclassified as not having hypertension. Source: https://academic.oup.com/aje/article-abstract/185/3/194/2915788/Prevalence-of-Masked-Hypertension-Among-US-Adults

Monday, May 4, 2026

Zetia: Dosage Guide And Timing Considerations

Taking medication correctly is just as important as choosing the right one. For Zetia (ezetimibe), following the prescribed or recommended dosage schedule consistently is essential to achieving and maintaining therapeutic effects. The pharmacokinetic profile of ezetimibe determines how quickly it is absorbed, how long it stays active in the body, and how often it needs to be taken. Elevated blood cholesterol is a major risk factor for cardiovascular disease, the leading cause of death in many countries. Low-density lipoprotein cholesterol, often called LDL or bad cholesterol, contributes to the buildup of fatty plaques inside arterial walls, a process known as atherosclerosis. Over time, these plaques narrow the arteries and reduce blood flow, increasing the risk of heart attack and stroke. Managing cholesterol levels through lifestyle changes and, when necessary, medication is an important part of cardiovascular risk reduction. The standard dosing of Zetia varies depending on the condition being treated, the patient's age, weight, and kidney or liver function, and whether it is being used for acute symptom relief or chronic management. Full prescribing and dosage details, including dose adjustments for specific populations such as elderly patients or those with organ impairment, are available at https://mednewwsstoday.com/cholesterol-lowering/zetia-ezetimibe/. Consistency is key when taking Zetia. Skipping doses or stopping early can reduce the medication's effectiveness or, in some cases, allow the underlying condition to worsen. If a dose is missed, patients should generally take it as soon as they remember unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Doubling up to make up for a missed dose is not recommended for most medications. Those seeking comparative information on dosing and safety profiles across medications used for cholesterol management can refer to https://mednewwsstoday.com/cholesterol-lowering/, where detailed profiles of individual medications in this category are maintained for patient education.
Posted by at No comments:
Subscribe to: Posts (Atom)